171 related articles for article (PubMed ID: 27432084)
1. Identifying survival-associated ceRNA clusters in cholangiocarcinoma.
Wan M; Zhang FM; Li ZL; Kang PC; Jiang PM; Wang YM; Wang ZD; Zhong XY; Li CL; Wang H; Zhao SY; Cui YF
Oncol Rep; 2016 Sep; 36(3):1542-50. PubMed ID: 27432084
[TBL] [Abstract][Full Text] [Related]
2. Integrative Analysis of ceRNA Network Reveals Functional lncRNAs in Intrahepatic Cholangiocarcinoma.
Zhou D; Gao B; Yang Q; Kong Y; Wang W
Biomed Res Int; 2019; 2019():2601271. PubMed ID: 31886187
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of aberrantly expressed profiles of lncRNAs, miRNAs and mRNAs with associated ceRNA network in cholangiocarcinoma.
Wang X; Hu KB; Zhang YQ; Yang CJ; Yao HH
Cancer Biomark; 2018; 23(4):549-559. PubMed ID: 30452401
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of long noncoding RNA-associated competing endogenous RNA network in cholangiocarcinoma.
Song W; Miao DL; Chen L
Biochem Biophys Res Commun; 2018 Dec; 506(4):1004-1012. PubMed ID: 30404735
[TBL] [Abstract][Full Text] [Related]
5. Identification of Prognostic Factors in Cholangiocarcinoma Based on Integrated ceRNA Network Analysis.
Jin H; Liu W; Xu W; Zhou L; Luo H; Xu C; Chen X; Chen W
Comput Math Methods Med; 2022; 2022():7102736. PubMed ID: 36158120
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide identification of a competing endogenous RNA network in cholangiocarcinoma.
Li G; Liu T; Zhang B; Chen W; Ding Z
J Cell Biochem; 2019 Nov; 120(11):18995-19003. PubMed ID: 31270845
[TBL] [Abstract][Full Text] [Related]
7. Identification and functional characterization of lncRNAs acting as ceRNA involved in the malignant progression of glioblastoma multiforme.
Zhang K; Li Q; Kang X; Wang Y; Wang S
Oncol Rep; 2016 Nov; 36(5):2911-2925. PubMed ID: 27600337
[TBL] [Abstract][Full Text] [Related]
8. Role of the long non-coding RNA PVT1 in the dysregulation of the ceRNA-ceRNA network in human breast cancer.
Conte F; Fiscon G; Chiara M; Colombo T; Farina L; Paci P
PLoS One; 2017; 12(2):e0171661. PubMed ID: 28187158
[TBL] [Abstract][Full Text] [Related]
9. Identification of Potential Prostate Cancer-Related Pseudogenes Based on Competitive Endogenous RNA Network Hypothesis.
Jiang T; Guo J; Hu Z; Zhao M; Gu Z; Miao S
Med Sci Monit; 2018 Jun; 24():4213-4239. PubMed ID: 29923546
[TBL] [Abstract][Full Text] [Related]
10. Building a Competing Endogenous RNA Network to Find Potential Long Non-Coding RNA Biomarkers for Pheochromocytoma.
Liang YC; Wu YP; Chen DN; Chen SH; Li XD; Sun XL; Wei Y; Ning X; Xue XY
Cell Physiol Biochem; 2018; 51(6):2916-2924. PubMed ID: 30562748
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide analysis of long noncoding RNA and mRNA co-expression profile in intrahepatic cholangiocarcinoma tissue by RNA sequencing.
Yang W; Li Y; Song X; Xu J; Xie J
Oncotarget; 2017 Apr; 8(16):26591-26599. PubMed ID: 28427159
[TBL] [Abstract][Full Text] [Related]
12. Competing endogenous RNA networks and gastric cancer.
Guo LL; Song CH; Wang P; Dai LP; Zhang JY; Wang KJ
World J Gastroenterol; 2015 Nov; 21(41):11680-7. PubMed ID: 26556995
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive characterization of lncRNA-mRNA related ceRNA network across 12 major cancers.
Zhang Y; Xu Y; Feng L; Li F; Sun Z; Wu T; Shi X; Li J; Li X
Oncotarget; 2016 Sep; 7(39):64148-64167. PubMed ID: 27580177
[TBL] [Abstract][Full Text] [Related]
14. CeRNA regulatory network-based analysis to study the roles of noncoding RNAs in the pathogenesis of intrahepatic cholangiocellular carcinoma.
Xu W; Yu S; Xiong J; Long J; Zheng Y; Sang X
Aging (Albany NY); 2020 Jan; 12(2):1047-1086. PubMed ID: 31956102
[TBL] [Abstract][Full Text] [Related]
15. TCGA dataset‑based construction and integrated analysis of aberrantly expressed long non‑coding RNA mediated competing endogenous RNA network in gastric cancer.
He W; Zhang D; Li X; Wu J; Yang X; Wang Q; Lu W; Jiang J; Wu C
Oncol Rep; 2018 Dec; 40(6):3511-3522. PubMed ID: 30272352
[TBL] [Abstract][Full Text] [Related]
16. Competing endogenous RNA network analysis identifies critical genes among the different breast cancer subtypes.
Chen J; Xu J; Li Y; Zhang J; Chen H; Lu J; Wang Z; Zhao X; Xu K; Li Y; Li X; Zhang Y
Oncotarget; 2017 Feb; 8(6):10171-10184. PubMed ID: 28052038
[TBL] [Abstract][Full Text] [Related]
17. Construction and analysis for differentially expressed long non-coding RNAs and MicroRNAs mediated competing endogenous RNA network in colon cancer.
Li F; Li Q; Wu X
PLoS One; 2018; 13(2):e0192494. PubMed ID: 29420609
[TBL] [Abstract][Full Text] [Related]
18. CLDN5 affects lncRNAs acting as ceRNA dynamics contributing to regulating blood‑brain barrier permeability in tumor brain metastasis.
Ma SC; Li Q; Peng JY; Zhouwen JL; Zhang DN; Zhang CB; Jiang WG; Jia W
Oncol Rep; 2018 Mar; 39(3):1441-1453. PubMed ID: 29328410
[TBL] [Abstract][Full Text] [Related]
19. The gain and loss of long noncoding RNA associated-competing endogenous RNAs in prostate cancer.
Liu D; Yu X; Wang S; Dai E; Jiang L; Wang J; Yang Q; Yang F; Zhou S; Jiang W
Oncotarget; 2016 Aug; 7(35):57228-57238. PubMed ID: 27528026
[TBL] [Abstract][Full Text] [Related]
20. Identification of laryngeal cancer prognostic biomarkers using an inflammatory gene-related, competitive endogenous RNA network.
He Q; Tian L; Jiang H; Zhang J; Li Q; Sun Y; Zhao J; Li H; Liu M
Oncotarget; 2017 Feb; 8(6):9525-9534. PubMed ID: 27902487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
